BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19

• Press Releases

  Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders

  June 19, 2026

   · 

  1 min read
• Press Releases

  Memento Medicines Launches with $93 Million Series A Financing to advance Tie2 Agonist and VEGF Inhibitor Bispecific Antibody Therapy for Retinal Diseases

  June 19, 2026

   · 

  7 min read
• Press Releases

  Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine

  June 19, 2026

   · 

  4 min read
• Press Releases

  Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome

  June 19, 2026

   · 

  5 min read
• Press Releases

  bioAffinity Technologies Announces Closing of $3.2 Million Offering

  June 19, 2026

   · 

  4 min read
• Press Releases

  Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET

  June 19, 2026

   · 

  3 min read
• Press Releases

  Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 18, 2026

  June 19, 2026

   · 

  1 min read
• Press Releases

  Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 18, 2026

  June 19, 2026

   · 

  2 min read
• Press Releases

  Autonomix Announces Reverse Stock Split

  June 19, 2026

   · 

  3 min read
• Press Releases

  Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

  June 19, 2026

   · 

  9 min read